Sepsis is a complex, heterogeneous physiologic condition that represents a significant public health concern. While many insights into the pathophysiology of sepsis have been elucidated over the past decades of research, important questions remain. This article serves as a review of several important areas in sepsis research. Understanding the innate immune response has been at the forefront as of late, especially in the context of cytokine-directed therapeutic trials. Cellular bioenergetic changes provide insight into the development of organ dysfunction in sepsis. Autophagy and mitophagy perform crucial cell housekeeping and stress response functions. Finally, age-related changes and their potential impact on the septic response are reviewed.
Get full access to this article
View all access options for this article.
References
1.
AngusDC, Linde-ZwirbleWT, LidickerJ, et al.Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med, 2001; 29:1303–1310.
2.
MartinGS, ManninoDM, EatonS, MossM. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med, 2003; 348:1546–1554.
3.
DombrovskiyVY, MartinAA, SunderramJ, PazH. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med, 2007; 35:1244–1250.
4.
KumarG, KumarN, TanejaA, et al.Nationwide trends of severe sepsis in the 21st century (2000–2007). Chest, 2011; 140:1223–1231.
5.
RiversE, NguyenB, HavstadS, et al.Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med, 2001; 345:1368–1377.
6.
OteroRM, NguyenHB, HuangDT, et al.Early goal-directed therapy in severe sepsis and septic shock revisited. Chest, 2006; 130:1579–1595.
7.
IwasakiA, MedzhitovR. Regulation of adaptive immunity by the innate immune system. Science, 2010; 327:291–295.
8.
BrozP, MonackDM. Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol, 2013; 13:551–565.
9.
CarpenterS, O'NeillLA. How important are toll-like receptors for antimicrobial responses?. Cell Microbiol, 2007; 9:1891–1901.
10.
PoltorakA, HeX, SmirnovaI, et al.Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science, 1998; 282:2085–2088.
11.
DengM, ScottMJ, LoughranP, et al.Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of TLR4 during sepsis. J Immunol, 2013; 190:5152–5160.
12.
WaltzPK, CarchmanEH, YoungAC, et al.Lipopolysaccharide induces autophagic signaling in macrophages via a TLR4, heme oxygenase-1 dependent pathway. Autophagy, 2011; 7:315–320.
13.
RossignolDP, WasanKM, ChooE, et al.Safety, pharmacokinetics, pharmacodynamics, and plasma lipoprotein distribution of eritoran (E5564) during continuous intravenous infusion into healthy volunteers. Antimicrob Agents Chemother, 2004; 48:3233–3240.
14.
BarochiaA, SolomonS, CuiX, et al.Eritoran tetrasodium (E5564) treatment for sepsis: Review of preclinical and clinical studies. Expert Opin Drug Metab Toxicol, 2011; 7:479–494.
15.
OpalSM, LaterrePF, FrancoisB, et al.Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: The ACCESS randomized trial. JAMA, 2013; 309:1154–1162.
YasudaK, YuP, KirschningCJ, et al.Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J Immunol, 2005; 174:6129–6136.
25.
AngusDC, van der PollT. Severe sepsis and septic shock. N Engl J Med, 2013; 369:840–851.
Van den BergheG, de ZegherF, BouillonR. Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab, 1998; 83:1827–1834.
28.
SingerM, De SantisV, VitaleD, JeffcoateW. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet, 2004; 364:545–548.
29.
SingerM. Mitochondrial function in sepsis: Acute phase versus multiple organ failure. Crit Care Med, 2007; 35:S441–S448.
30.
CarreJE, SingerM. Cellular energetic metabolism in sepsis: The need for a systems approach. Biochim Biophys Acta, 2008; 1777:763–771.
31.
SingerM. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence, 2014; 5:66–72.
32.
FinkMP. Bench-to-bedside review: Cytopathic hypoxia. Crit Care, 2002; 6:491–499.
33.
HadenDW, SulimanHB, CarrawayMS, et al.Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. Am J Respir Crit Care Med, 2007; 176:768–777.
34.
CalvanoSE, XiaoW, RichardsDR, et al.A network-based analysis of systemic inflammation in humans. Nature, 2005; 437:1032–1037.
35.
CarreJE, OrbanJC, FelsmannK, et al.Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med, 2010; 182:745–751.
36.
LeeI, HüttemannM. Energy crisis: The role of oxidative phosphorylation in acute inflammation and sepsis. Biochim Biophys Acta, 2014; 1842:1579–1586.
37.
WhelanSP, CarchmanEH, KautzaB, et al.Polymicrobial sepsis is associated with decreased hepatic oxidative phosphorylation and an altered metabolic profile. J Surg Res, 2014; 186:297–303.
38.
MillsE, O'NeillLA. Succinate: A metabolic signal in inflammation. Trends Cell Biol, 2014; 24:313–320.
39.
PearceEL, PearceEJ. Metabolic pathways in immune cell activation and quiescence. Immunity, 2013; 38:633–643.
40.
BrealeyD, BrandM, HargreavesI, et al.Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet, 2002; 360:219–223.
41.
LeverveXM. Mitochondrial function and substrate availability. Crit Care Med, 2007; 35:S454–S460.
42.
KreymannG, GrosserS, BuggischP, et al.Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome, and septic shock. Crit Care Med, 1993; 21:1012–1019.
43.
DelgadoM, SinghS, De HaroS, et al.Autophagy and pattern recognition receptors in innate immunity. Immunol Rev, 2009; 227:189–202.
44.
KlionskyDJ, EmrSD. Autophagy as a regulated pathway of cellular degradation. Science, 2000; 290:1717–1721.
YorimitsuT, KlionskyDJ. Autophagy: Molecular machinery for self-eating. Cell Death Differ, 2005; 12:1542–1552.
47.
ParzychKR, KlionskyDJ. An overview of autophagy: Morphology, mechanism, and regulation. Antioxid Redox Signal, 2014; 20:460–473.
48.
WirawanE, Vanden BergheT, LippensS, et al.Autophagy: For better or for worse. Cell Res, 2012; 22:43–61.
49.
KabeyaY, MizushimaN, UenoT, et al.LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J, 2000; 19:5720–5728.
50.
MeansAR. The year in basic science: Calmodulin kinase cascades. Mol Endocrinol, 2008; 22:2759–2765.
51.
NakayamaY, EndoM, TsukanoH, et al.Molecular mechanisms of the LPS-induced non-apoptotic ER stress-CHOP pathway. J Biochem, 2010; 147:471–483.
52.
Høyer-HansenM, BastholmL, SzyniarowskiP, et al.Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol Cell, 2007; 25:193–205.
53.
ZhangX, GuoL, CollageRD, et al.Calcium/calmodulin-dependent protein kinase (CaMK) Iα mediates the macrophage inflammatory response to sepsis. J Leukoc Biol, 2011; 90:249–261.
54.
ZhangX, WheelerD, TangY, et al.Calcium/calmodulin-dependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages. J Immunol, 2008; 181:5015–5023.
55.
GuoL, StripayJL, ZhangX, et al.CAMKIα regulates AMP kinase-dependent, TORC-1-independent autophagy during lipopolysaccharide-induced acute lung neutrophilic inflammation. J Immunol, 2013; 190:3620–3628.
56.
WeiY, PattingreS, SinhaS, et al.JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol Cell, 2008; 30:678–688.
57.
CarchmanEH, RaoJ, LoughranPA, et al.Heme oxygenase-1–mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice. Hepatology, 2011; 53:2053–2062.
58.
KimHS, LoughranPA, BilliarTR. Carbon monoxide decreases the level of iNOS protein and active dimer in IL-1beta-stimulated hepatocytes. Nitric Oxide, 2008; 18:256–265.
59.
SarkarS, KorolchukVI, RennaM, et al.Complex inhibitory effects of nitric oxide on autophagy. Mol Cell, 2011; 43:19–32.
60.
MaiuriMC, ZalckvarE, KimchiA, KroemerG. Self-eating and self-killing: Crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol, 2007; 8:741–752.
61.
GuirgisFW, KhadpeJD, KuntzGM, et al.Persistent organ dysfunction after severe sepsis: A systematic review. J Crit Care, 2014; 29:320–326.
62.
HotchkissRS, SwansonPE, FreemanBD, et al.Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med, 1999; 27:1230–1251.
63.
CrouserED, JulianMW, HuffJE, et al.Carbomoyl phosphate synthase-1: A marker of mitochondrial damage and depletion in the liver during sepsis. Crit Care Med, 2006; 34:2439–2446.
64.
DedkovaEN, BlatterLA. Mitochondrial Ca2+ and the heart. Cell Calcium, 2008; 44:77–91.
65.
KubliDA, GustafssonAB. Mitochondria and mitophagy: The yin and yang of cell death control. Circ Res, 2012; 111:1208–1221.
66.
NakahiraK, HaspelJA, RathinamVA, et al.Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol, 2011; 12:222–230.
ZangQS, WolfSE, MineiJP. Sepsis-induced cardiac mitochondrial damage and potential therapeutic interventions in the elderly. Aging Dis, 2014; 5:137–149.
69.
HammerlingBC, GustafssonAB. Mitochondrial quality control in the myocardium: Cooperation between protein degradation and mitophagy. J Mol Cell Cardiol, 2014; 75:122–130.
70.
ErmakG, DaviesKJ. Calcium and oxidative stress: From cell signaling to cell death. Mol Immunol, 2002; 38:713–721.
KawamataH, ManfrediG. Mitochondrial dysfunction and intracellular calcium dysregulation in ALS. Mech Ageing Dev, 2010; 131:517–526.
73.
RasbachKA, SchnellmannRG. PGC-1alpha over-expression promotes recovery from mitochondrial dysfunction and cell injury. Biochem Biophys Res Commun, 2007; 355:734–739.
74.
WuZ, PuigserverP, AnderssonU, et al.Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell, 1999; 98:115–124.
75.
NisoliE, ClementiE, PaolucciC, et al.Mitochondrial biogenesis in mammals: The role of endogenous nitric oxide. Science, 2003; 299:896–899.
76.
SulimanHB, Welty-WolfKE, CarrawayMS, et al.Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. coli. FASEB J, 2005; 19:1531–1533.
77.
CarchmanEH, WhelanS, LoughranP, et al.Experimental sepsis-induced mitochondrial biogenesis is dependent on autophagy, TLR4, and TLR9 signaling in liver. FASEB J, 2013; 27:4703–4711.
78.
WuH, KanatousSB, ThurmondFA, et al.Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science, 2002; 296:349–352.
79.
ChanDC. Mitochondria: Dynamic organelles in disease, aging, and development. Cell, 2006; 125:1241–1252.
80.
ZahnJM, SonuR, VogelH, et al.Transcriptional profiling of aging in human muscle reveals a common aging signature. PLoS Genet, 2006; 2:1058–1069.
81.
BraticA, LarssonNG. The role of mitochondria in aging. J Clin Invest, 2013; 123:951–957.
82.
HarmanD. Aging: A theory based on free radical and radiation chemistry. J Gerontol, 1956; 11:298–300.
83.
AmaraCE, ShanklandEG, JubriasSA, et al.Mild mitochondrial uncoupling impacts cellular aging in human muscles in vivo. Proc Natl Acad Sci USA, 2007; 104:1057–1062.
84.
RodellA, RasmussenLJ, BergersonLH, SinghKK, GjeddeA. Natural selection of mitochondria during somatic lifetime promotes healthy aging. Front Neuroenergetics, 2013; 5:1–6.
85.
HowellGM, GomezH, CollageRD, et al.Augmenting autophagy to treat acute kidney injury during endotoxemia in mice. PLoS One, 2013; 8:1–7.
